Ten-year review of the clinical presentation and treatment outcome of Asherman’s syndrome in university of Maiduguri teaching hospital, Borno State, Nigeria

Ado Danazumi Geidam, Adamu Malgwi


Background: Asherman’s syndrome (AS) is an important gynaecological disorder characterized by a menstrual abnormality (hypomenorrhea/amenorrhea) and infertility that is usually caused by activities that traumatize the endometrium. Objective of current study was to determine the prevalence, clinical presentation and treatment outcome of Asherman’s syndrome in our hospital.

Methods: A retrospective review of patients with Asherman’s syndrome managed at the University of Maiduguri Teaching hospital over 10 years (January 2008 to December 2017). Data about the patients were obtained and analyzed using Microsoft office excel 2007 and SPSS version 25 (IBM SPSS, Statistics) to generate descriptive statistics (frequencies, ratio and percentages) which were presented as tables.

Results: The prevalence of AS is 5.3%. Most of the patients were in the 25-34 age group (69.1%) and the majority (94.5%) were married. Dilatation and curettage (D & C) constituted the commonest risk factor for Asherman’s syndrome (21/55, 38.2%) and infertility alone (29, 52.7%), and hypomenorrhea with infertility 10 (18.2%) were the commonest presentation. Twenty-five percent of the patients (14/55) achieved normal menses and 11 (20%) achieved pregnancy following treatment.

Conclusions: AS is not uncommon in our environment. D&C is the commonest risk factor and the patients usually present with infertility and hypomenorrhea.



Asherman’s syndrome, Achieve pregnancy, D and C, Infertility, UMTH

Full Text:



Amenorrhea, In; Hoffman, Schoffer, Bradshaw, Schorge, Halvorson, Cunningham(ed). Williams Gynaecology, 2nd ed. United States of America: McGraw-Hill companies Inc; 2012:16;440-57.

Alex S, Wendy YC, Alan HD. In; Decherney AH, Nathan L, Laufer N, Ashley RS eds. Current diagnosis and treatment, Obstetric and gynaecology. 11th ed. United States of America: McGraw-Hill companies Inc; 2013:54;889-99.

Opadiran RO, Isah AD, Agida ET, Adewole N. Outcome of intrauterine adhesion management at a Nigerian tertiary hospital; a five year review. Int J Reprod Contracept Obstet Gynecol. 2018;7:375-9.

Ajayi A B, Afolabi B M, Ajayi V, Biobaba O, et al. Risk factors for intrauterine adhesions in a black African population. Nigerians. Gynecol Obstet. 2017; 7:436.

Chanrit P, Tawiwan P, Opas S, Usanee S. Intrauterine adhesions: causes and treatment outcomes among Thai women. J med Assoc Thai. 2016;99(10):1067-72.

Charles N, Cahethan E, Edu E, Boniface A, John E. Risk factors and management outcome of intrauterine adhesion in a constrained socioeconomic environment: a 10 year review in the university of Calabar teaching hospital, Calabar. EJPM. 2017;4(3): 25-30.

Kwari SD, Idrisa A. Intrauterine adhesions at the university of Maiduguri teaching hospital, Maiduguri, Nigeria. A 3 year review. Trop J Obstet Gynecol. 2011;28(10):50-1.

Saroja CSM, Nankani A, El-Hamamy E. Uterine compression sutures,an update:review of efficacy, safety and complications of B-Lynch suture and other uterine compression techniques for postpartum haemorrhage. Arch Gynecol Obstet. 2010;281(4):581-8.

Utuk N, Abasiattai A M, Asuquo O. Intrauterine adhesion in the university of Uyo teaching hospital, south-south, Nigeria. A 10 year review. Trop J Obstet Gynecol. 2019;6:39-43

Dreisler E, Kjer JJ. In Asherman’s syndrome;current perspectives on diagnosis and management. Int J Women’s Health. 2019;11:191-8.

Neeta S, Sujata M, Sona D. Autologous stem cell transplantation in refractory Asherman’s syndrome: A novel cell based therapy. J Hum Reprod Sci. 2014; 7(2):93-8.

Changjiang L, Jia W. The study on the safety and efficacy of amnion graft for preventing the recurrence of moderate to severe intrauterine adhesions. Genes Dis. 2020;7(2):266-71.

Gaya SA, Adamu IS, Yakasai IA. Review of intrauterine adhesiolysis at the Aminu Kano Teaching Hospital, Kano, Nigeria. Ann Afr Med. 2012;11(2): 65-9.

Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome-one century later. Fertil Steril. 2008;89:759-79.

Chen Y, Chang Y, Yao S. Role of angiogenesis in endometrial repair of patients with severe intrauterine adhesion. Int J Clin Exp Pathol. 2013;15:1343-50.

Polishuk WZ, Anteby SO, Weinstein D: Puerperal endometritis and intrauterine adhesions. Int Surg. 1975;60:418-20.

Abiodun OM, Balogun OR, Fawole AA. Aetiology, clinical features and treatment outcome of intrauterine adhesion in Ilorin, Central Nigeria. West Afr J Med. 2007;26:298-301.

Bhandari Sh, Bhave P, Ganguly I, Baxi A, Agarwal P. Reproductive Outcome of Patients with Asherman’s Syndrome: A SAIMS Experience. J Reprod Infertil. 2015;16(4):229-35.

Valle RF, Sciarra JJ. Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome. Am J Obstet Gynecol. 1988; 158(6):1459-70.

Yamamoto N, Takeuchi R, Izuchi D. Hysteroscopic adhesiolysis for patients with Asherman’s syndrome: menstrual and fertility outcomes. Reprod Med Biol. 2013;12(4):159-66.